Processa Pharmaceuticals, Inc. (PCSA) Total Assets by Year
Processa Pharmaceuticals, Inc. closed fiscal year 2025 with $7.8M in total assets, $2.2M in total liabilities and $5.6M in shareholder equity. This represents an increase of 142.0% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Processa Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PCSA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.8M+142.0% | $3.2M-44.2% | $5.8M-32.9% | $8.6M-67.4% | $26.5M+5.0% | $25.2M+131.7% | $10.9M-12.8% | $12.5M+318.4% | $3.0M+26.1% | $2.4M+2167.0% | $104K-95.9% | $2.5M-13.3% | $2.9M-24.4% | $3.9M |
| Total Liabilities | $2.2M+45.9% | $1.5M+92.2% | $797K-30.6% | $1.1M+17.4% | $978K-57.0% | $2.3M-20.8% | $2.9M+3.3% | $2.8M+6.5% | $2.6M-43.7% | $4.6M+2337.6% | $190K-85.8% | $1.3M+5.6% | $1.3M-4.1% | $1.3M |
| Total Equity | $5.6M+228.8% | $1.7M-66.0% | $5.0M-33.2% | $7.5M-70.7% | $25.5M+11.1% | $22.9M+186.3% | $8.0M-17.4% | $9.7M+2499.7% | $373K+116.5% | -$2.3M-2545.4% | -$86K-107.1% | $1.2M-27.7% | $1.7M-34.8% | $2.6M |
PCSA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1M-74.7% | $4.5M-6.0% | $7.8M+142.0% | $7.6M+53.5% | $8.2M+7.6% | $4.8M-51.6% | $3.2M-44.2% | $4.9M-38.9% | $7.6M-24.7% | $9.9M-20.0% | $5.8M-32.9% | $8.1M-56.6% |
| Total Liabilities | $2.4M+15.1% | $2.0M+54.3% | $2.2M+45.9% | $1.8M+43.4% | $2.1M+31.5% | $1.3M+20.9% | $1.5M+92.2% | $1.2M+33.5% | $1.6M+69.5% | $1.1M-53.7% | $797K-30.6% | $915K-33.0% |
| Total Equity | -$317K-105.2% | $2.5M-28.0% | $5.6M+228.8% | $5.8M+56.8% | $6.1M+1.4% | $3.5M-60.3% | $1.7M-66.0% | $3.7M-48.1% | $6.0M-34.2% | $8.9M-12.4% | $5.0M-33.2% | $7.2M-58.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Processa Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Processa Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
Processa Pharmaceuticals, Inc. closed fiscal year 2025 with $7.8M in total assets, $2.2M in total liabilities and $5.6M in shareholder equity.
How fast is Processa Pharmaceuticals, Inc.'s total assets growing?
Processa Pharmaceuticals, Inc. (PCSA) total assets rose by 142.0% year over year, from $3.2M to $7.8M in fiscal year 2025.
How has Processa Pharmaceuticals, Inc.'s total assets changed over the years?
Across the 14 fiscal years this page covers, Processa Pharmaceuticals, Inc. (PCSA) total assets went from $3.9M in fiscal year 2012 to $7.8M in fiscal year 2025.
What was Processa Pharmaceuticals, Inc.'s total assets in the most recent quarter?
Processa Pharmaceuticals, Inc. (PCSA) reported $2.1M in total assets in Q2 2026. This represents a decrease of 74.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Processa Pharmaceuticals, Inc. (PCSA) reported on that line in every period on record.